Intech Investment Management LLC Seagen Inc. Transaction History

Intech Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $1.94 Million - $2.19 Million	-10,148 Reduced 41.28%	14,438 $3.06 Million
Q2 2023 Aug 09, 2023	BUY	$187.64 - $206.25 $1.44 Million - $1.58 Million	7,662 Added 45.27%	24,586 $4.73 Million
Q1 2023 May 10, 2023	BUY	$127.59 - $203.08 $482,928 - $768,657	3,785 Added 28.81%	16,924 $3.43 Million
Q4 2022 Feb 09, 2023	SELL	$117.37 - $139.17 $806,801 - $956,654	-6,874 Reduced 34.35%	13,139 $1.69 Million
Q3 2022 Nov 10, 2022	SELL	$135.27 - $180.11 $127,289 - $169,483	-941 Reduced 4.49%	20,013 $2.74 Million

Q2 2022 Aug 10, 2022	BUY	$108.81 - $179.33 $2.28 Million - $3.76 Million	20,954 New	20,954 $3.71 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Intech Investment Management LLC with notifications on news.